Femtech in 2025: Is it finally getting the attention it deserves?
Between 2018 and 2023, VC investment in women's health grew by 300%.
In 2024, femtech startups secured $1.4 billion —? 49.89% more than in 2023.
By 2033, the women’s health market is slated to reach $59.45 billion, compared with $42.57 billion in 2024.
Is it just us, or are we witnessing a dynamic transformation of femtech from a niche sector to an attractive investment opportunity (and a competitive moat for some)??
? The US government funneling $500 million toward women’s health research in 2024.
? WHAM's initiative bringing together leading multi-billion-dollar investment funds to promote women's healthcare innovation investment.
? Strides in biotech and telehealth, driving the growth of femtech.
We have a sneaky feeling that 2025 could be THE year for women’s health startups.
While we’re still early into 2025, we’d like to take you through high-growth opportunities in femtech.
Women’s health tech sector is to expand horizontally
Women's health solutions disproportionately focus on the 5% of conditions exclusive to women, like reproductive health concerns.?
But there’s this other untapped 95%, including conditions like autoimmune, neurology, and cardio-metabolic diseases that affect women either disproportionally or differently. And that's where immense innovation and investment opportunities lie.
Startups to watch: Systole Health, Elyfia, Bone Health.
Enablers. Startups driving innovation in the untapped areas need sex-disaggregated data to crack the code on how specific diseases affect women's health. Wearables, remote monitoring, and AI are game-changers here, allowing companies to create personalized treatments based on a woman's specific health profile, medical history, and lifestyle.
More precise diagnostics, even at home
Women have a long history of experiencing a "diagnostic odyssey" marked by uncertainty and medical gaslighting. Women and racial and ethnic minorities are at higher risk of misdiagnosis, with a 20% to 30% greater likelihood than white men.?
But there's hope: point-of-care diagnostics, AI-enhanced imaging tools, and at-home testing kits focused specifically on women’s health have the potential to put an end to various conditions and diseases being chalked up to period pain, anxiety, and depression.?
The growing market echoes the need: by 2030, the global women’s health diagnostics market is expected to surpass $31 billion, up from $20.6 billion in 2024.?
Startups to watch: PinkDx, Teal Health, Q-pad.?
Enablers. Wearables stand at the heart of accurate remote diagnostics. Equipped with sensitive and specific sensors that can detect relevant biomarkers in small sample volumes, wearables can ensure reliable diagnostic data. AI-enabled data analysis can pick up on early warning signs of potential health issues and stack up results against personalized baseline data.
Femtech+biopharma = sex parity in drug development
Clinical trials are historically known for skewing towards white male study participants, while women, especially women of color, used to be left out or underrepresented.
In 2025, the women’s clinical trial market continues to grapple with political dynamics at both federal and state levels. But the sector’s resilience post-Dobbs — marked by companies successfully adapting their services and experience — demonstrated that the market has the capacity to thrive under regulatory pressure.
The increased focus on diversity in trials and a fresh understanding of female biology are creating a fertile ground for the growth in biotechs focused on women's health.
Startups to watch: Research Grid, Health in Her HUE, Bayer+Impli.
Enablers. To integrate a sex-based lens, biotechs require tools to collect and analyze data on drug adoption rates, efficacy, and safety outcomes disaggregated by both sex and gender — tools that are currently lacking.
领英推荐
Weary women resort to wearables
93% of menopausal women are interested in noninvasive tech solutions to track, understand, and relieve associated symptoms. Tired of compromising on health, women demand tools that put them in the driver's seat of their own well-being, allowing them to get in tune with their bodies and improve their health.
Despite demand being in the room with us, many wearable startups drop the ball.?
46% of women feel neutral, somewhat, or very dissatisfied with their wearables because they are: a) inaccurate and unreliable, b) pricey, and c) uncomfortable or unappealing to wear.
Startups to watch: Evie Ring, Samphire Neuroscience, Femtek, Amber Therapeutics.
Enablers. Customer trust hinges on accuracy, and wearable startups can respond by making customer wearables as accurate as medical devices for key metrics. To go beyond mere metric tracking, wearables require data analytics and predictive AI that can suggest lifestyle adjustments and align with each user’s unique wellness journey.
Unstoppable momentum for mental health innovation
The history of women’s mental health is a narrative marred by words like ‘misconceptions,’ ‘misdiagnoses,’ and ‘dangerous treatments’. For the record, more than 1 in 20 women had mental health conditions or autism misdiagnosed.
While they can’t single-handedly flip the script, mental health startups can create a supportive environment for women by recognizing gender-based disparities and offering effective mental health solutions.
Startups to watch: Curio, ReMinded, Seven Starling, LunaJoy.
Enablers. Along with gender-neutral data, mental health applications for women should be able to analyze gender-specific data, such as hormonal fluctuations and reproductive stages. These data must also be analyzed through a gender lens (e.g., gendered manifestation of symptoms).
Convenient care, on women’s terms
About 60% of telehealth users are female. This number is hardly surprising, as women are 76% more likely than men to use healthcare services in general.?
However, women’s enthusiasm for telemedicine reflects a broader issue, which is a long-standing stigma associated with female bodies. Sexual and reproductive health concerns still remain topics too sensitive to be broached in the open — while telemedicine apps offer a more private and less intimidating way to seek care.
Now, factor in the growing OB/GYN shortage, barriers to healthcare access in rural areas, and increasing costs of traditional healthcare — and it’s clear why telemedicine is finding a strong foothold among women in 2025.
Startups to watch: Elektra Health, Midi, Maven Clinic, Gabbi.
Enablers. Telemedicine’s potential hinges on apps that can thrive even where broadband is scarce. To operate in areas with inadequate broadband infrastructure, telemedicine apps should be designed with low-bandwidth optimization and offline functionality in mind.
Undervalued no more (?)
Why the question mark, you ask? Well, for femtech startups to succeed in their aspirations, they need more than tech enablers.?
Adequate funding, gender equality in research, government support, affordability, interoperability, and collaboration across stakeholders are some of the milestones femtech startups have yet to achieve.
We understand these challenges. At Orangesoft, we help build meaningful femtech products, from concept to launch, while helping you navigate the challenging femtech landscape. Hit us up for a development quote.
Further reading:
Blueprint to close the women’s health gap: How to improve lives and economies for all (McKinsey Health Institute)
Women’s health impact tracking platform (World Economic Forum)